Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients.

MLA

Elsayed, Fadwa A., et al. “Use of Sanger and Next-Generation Sequencing to Screen for Mosaic and Intronic APC Variants in Unexplained Colorectal Polyposis Patients.” Familial Cancer, vol. 21, no. 1, Jan. 2022, pp. 79–83. EBSCOhost, https://doi.org/10.1007/s10689-021-00236-2.

APA

Elsayed, F. A., Tops, C. M. J., Nielsen, M., Morreau, H., Hes, F. J., & van Wezel, T. (2022). Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients. Familial Cancer, 21(1), 79–83. https://doi.org/10.1007/s10689-021-00236-2

Chicago

Elsayed, Fadwa A., Carli M. J. Tops, Maartje Nielsen, Hans Morreau, Frederik J. Hes, and Tom van Wezel. 2022. “Use of Sanger and Next-Generation Sequencing to Screen for Mosaic and Intronic APC Variants in Unexplained Colorectal Polyposis Patients.” Familial Cancer 21 (1): 79–83. doi:10.1007/s10689-021-00236-2.